Atlas FDA

Etest PIP/TAZO/CON-4 PTC 256 - Foam of 100 tests WW. Etest is a quantitative technique for determining the antimicrobial

FDA device recall Z-0441-2016 · posted 2015-12-23 · Terminated

Recall details

Recalling firm
Biomerieux
Reason for recall
Due to the potential for reporting erroneous results for Piperacillin/Tazobactam; specifically false susceptible results.
Action taken
Consignees (Subsidiaries and Distributors) of bioMrieux, impacted by the identified issue, were notified of the FSCA and corrective action (FSCA notification) electronically on November 24th, 2015. Additionally, the bioMrieux United States subsidiary notified US consignees (distributors/end-users) of the FSCA notification via FedEx on December 2nd, 2015.
Root cause
Process change control
Status
Terminated
Product code
JWY
Quantity affected
2495 units
Distribution
Worldwide Distribution- US Nationwide including DC and the states of AK, AL, AR, AZ, CA, CO, CT, FL, GS, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK,
Date initiated
2015-11-19
Date posted
2015-12-23
Date terminated
2017-06-19
Location
Letoile, France

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
PIPERACILIN TAZOBACTAM 4 UG (K953223)Ab Biodisk1995-08-15